LONDON, GREATER LONDON, UNITED KINGDOM, October 11, 2025 /EINPresswire.com/ -- How Big Is The Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market In 2025? The mRNA capping enzyme market has seen ...

A tiny molecule called a nanobody may succeed where today's cancer drugs often fail, according to University of Hawaiʻi at ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast: What To Expect By 2025? In recent years, the ...

Scientists say they have developed a nanoparticle -- an extremely tiny biodegradable container -- that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines for ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

CHARLESTON, S.C. (WCSC) - The Trump administration started to cut funding from messenger ribonucleic acid vaccine research earlier this month, impacting more than 20 contracts for vaccine development.

Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.

Researchers at IBM and Moderna have successfully used a quantum simulation algorithm to predict the complex secondary protein structure of a 60-nucleotide-long mRNA sequence, the longest ever ...

Abstract: In one important chemical engineering unit operation of messenger ribonucleic acid (mRNA) vaccine manufacture, the precious mRNA payload is encapsulated in lipid nanoparticles. Recent ...

CureVac was founded in 2000, and its focus is on developing vaccines and therapies using messenger ribonucleic acid, or mRNA. mRNA offers several advantages, including cell-free, rapid, large-scale ...

Messenger RNA (mRNA) is a subtype of RNA. An mRNA molecule carries a portion of the DNA code to other parts of the cell for processing. mRNA is created during transcription. During the transcription ...